These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 26799973

  • 1. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Bagchi S, Agarwal S, Kalaivani M, Bhowmik D, Singh G, Mahajan S, Dinda A.
    Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
    [Abstract] [Full Text] [Related]

  • 2. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
    Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC, Toronto Glomerulonephritis Registry Group.
    J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
    [Abstract] [Full Text] [Related]

  • 3. Differential risk of remission and ESRD in childhood FSGS.
    Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB.
    Pediatr Nephrol; 2006 Mar; 21(3):344-9. PubMed ID: 16395603
    [Abstract] [Full Text] [Related]

  • 4. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
    Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH.
    Clin J Am Soc Nephrol; 2016 Oct 07; 11(10):1752-1759. PubMed ID: 27445167
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 07; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 6. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J, Radhakrishnan J.
    Adv Chronic Kidney Dis; 2014 Sep 07; 21(5):434-41. PubMed ID: 25168833
    [Abstract] [Full Text] [Related]

  • 7. Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults.
    Greenwood AM, Gunnarsson R, Neuen BL, Oliver K, Green SJ, Baer RA.
    Nephrology (Carlton); 2017 Jul 07; 22(7):520-530. PubMed ID: 27170059
    [Abstract] [Full Text] [Related]

  • 8. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.
    Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM.
    Rev Assoc Med Bras (1992); 2024 Jul 07; 70(4):e20230871. PubMed ID: 38716932
    [Abstract] [Full Text] [Related]

  • 9. Treatment and prognosis of primary focal segmental glomerulosclerosis.
    Ren H, Shen P, Li X, Pan X, Zhang Q, Feng X, Zhang W, Chen N.
    Contrib Nephrol; 2013 Jul 07; 181():109-18. PubMed ID: 23689573
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
    Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS.
    Am J Kidney Dis; 2021 Feb 07; 77(2):216-225. PubMed ID: 32791086
    [Abstract] [Full Text] [Related]

  • 11. Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis.
    Hao X, Xie J, Ma J, Wang Z, Zhou Q, Yang L, Pan X, Ren H, Chen N.
    Contrib Nephrol; 2013 Feb 07; 181():101-8. PubMed ID: 23689572
    [Abstract] [Full Text] [Related]

  • 12. Glucocorticoids in the treatment of patients with primary focal segmental glomerulosclerosis and moderate proteinuria.
    Huang J, Lin L, Xie J, Li X, Shen P, Pan X, Ren H, Chen N.
    Clin Exp Nephrol; 2018 Dec 07; 22(6):1315-1323. PubMed ID: 29761241
    [Abstract] [Full Text] [Related]

  • 13. Focal segmental glomerulosclerosis complicating solitary kidney.
    Oshiro Y, Umena S, Noda M.
    Clin Exp Nephrol; 2009 Feb 07; 13(1):81-4. PubMed ID: 18688570
    [Abstract] [Full Text] [Related]

  • 14. Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.
    Hubsch H, Montané B, Abitbol C, Chandar J, Shariatmadar S, Ciancio G, Burke G, Miller J, Strauss J, Zilleruelo G.
    Pediatr Nephrol; 2005 Feb 07; 20(2):210-6. PubMed ID: 15605284
    [Abstract] [Full Text] [Related]

  • 15. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
    Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G.
    Kidney Int; 2000 Oct 07; 58(4):1732-41. PubMed ID: 11012907
    [Abstract] [Full Text] [Related]

  • 16. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis: early treatment with plasmapheresis and immunoadsorption should be associated with better prognosis.
    Fencl F, Vondrák K, Rosík T, Zieg J, Chadimová M, Háček J, Dušek J, Seeman T.
    Minerva Pediatr; 2016 Oct 07; 68(5):348-54. PubMed ID: 26041001
    [Abstract] [Full Text] [Related]

  • 17. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
    Luna E, Cerezo I, Macias R, Villa J, Martinez C, Cubero J, Martinez R, Ferreira F, García C.
    Transplant Proc; 2011 Oct 07; 43(6):2187-90. PubMed ID: 21839229
    [Abstract] [Full Text] [Related]

  • 18. Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis--angiotensin II immunostaining and treatment outcome.
    Mizuiri S, Kawamura T, Miyagi M, Arai K, Sakai K, Aikawa A, Ohara T, Shibuya K, Ishikawa Y, Kawamura S, Hasegawa A.
    Clin Transplant; 2005 Oct 07; 19 Suppl 14():12-9. PubMed ID: 15955164
    [Abstract] [Full Text] [Related]

  • 19. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug 07; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 20. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
    Kidney Int; 2004 May 07; 65(5):1690-702. PubMed ID: 15086908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.